Volatile Stocks in List: Skyworks Solutions Inc. (NASDAQ:SWKS), CTI BioPharma Corp. (NASDAQ:CTIC), Teva Pharmaceutical Industries Limited (NYSE:TEVA)

Skyworks Solutions Inc. (NASDAQ:SWKS) swings sharply after it recently stated third fiscal quarter results for the period ending July 3, 2015. Income for the third fiscal quarter was $810.0 million, up 38 percent year-over-year and exceeding the Firm’s guidance of $800 million. “As the world becomes more interconnected, we are capitalizing on powerful secular growth trends, comprising the rising adoption of streaming media services, the proliferation of connectivity in emerging markets, and the Internet of Things—all of which are driving growth well in excess of the broader semiconductor market,” stated David J. Aldrich, chairman and chief executive officer of Skyworks. “At the same time, our industry-leading systems solutions are facilitating an expansion of our addressable markets, creating more planned consumer relationships, and enhancing the financial returns of our Firm. Looking ahead, we see tremendous prospects to leverage our capabilities across a broadening set of markets and applications.” Skyworks Solutions Inc. (NASDAQ:SWKS) stock price closed at $97.71 with the total traded volume of 10.48 Million shares. Its price to sales ratio ended at 3.95. Its market capitalization is 18.56 Billion. The stock owned by the Financial Institutions was 65.30% while by insiders was 3.50%.

CTI BioPharma Corp. (NASDAQ:CTIC) declared that appointment of Bruce Seeley as Executive Vice President and Chief Commercial Officer. Seeley will report to James Bianco, CTI BioPharma’s President and Chief Executive Officer. Seeley joins the biopharmaceutical company effective today. He will serve on the executive leadership team, assuming responsibility for CTI BioPharma’s commercial organization worldwide – including sales, marketing, commercial operations, medical affairs and supply chain. In connection with the transition of medical affairs to the new Chief Commercial Officer, Jack Singer assumes the position of Chief Scientific Officer and will continue to serve as Executive Vice President, Interim Chief Medical Officer and Global Head of Translational Medicine.  CTI BioPharma Corp. (NASDAQ:CTIC) has the market capitalization of 327.00 Million. Shares of firm plunged -2.08% to close at $1.88 with the total traded volume of 1.03 Million. The firm has current ratio of 1.50 for the most recent quarter.

Israeli generic drug maker, Teva Pharmaceutical Industries Limited (NYSE:TEVA) released on Monday that it has reached into a definitive agreement with Allergan plc (AGN) to acquire Allergan Generics in a transaction valued at $40.5 billion. Upon closing, Allergan will receive $33.75 billion in cash and shares of Teva valued today at $6.75 billion, representing an estimated under 10% ownership stake in Teva. Teva believes the acquisition will be significantly accretive to non-GAAP earnings per share, including expected double-digit non-GAAP EPS accretion in 2016 and more than 20% accretion in year two and year three following the close of the transaction.  Teva Pharmaceutical Industries Limited (NYSE:TEVA)begun last trade with a price of $62.27 and throughout the trading session climbed at a high of $62.65. The day-trade ended with -1.06% to $61.85.